The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Glaucoma is a neurodegenerative disease and the leading cause of irreversible blindness worldwide. Vision deficits in glaucoma result from the selective loss of retinal ganglion cells (RGC). Glial cell-mediated neuroinflammation has been proposed to contribute to disease pathophysiology, but whether this response is harmful or beneficial for RGC survival is not well understood. To test this, we characterized the role of ibudilast, a clinically approved cAMP phosphodiesterase (PDE) inhibitor with preferential affinity for PDE type 4 (PDE4). Here, we demonstrate that intraocular administration of ibudilast dampened macroglia and microglia reactivity in the retina and optic nerve hence decreasing production of proinflammatory cytokines in a rat model of ocular hypertension. Importantly, ibudilast promoted robust RGC soma survival, prevented axonal degeneration, and improved anterograde axonal transport in glaucomatous eyes without altering intraocular pressure. Intriguingly, ocular hypertension triggered upregulation of PDE4 subtype A in Müller glia, and ibudilast stimulated cAMP accumulation in these cells. Co-administration of ibudilast with Rp-cAMPS, a cell-permeable and non-hydrolysable cAMP analog that inhibits protein kinase A (PKA), completely blocked ibudilast-induced neuroprotection. Collectively, these data demonstrate that ibudilast, a safe and well-tolerated glial cell modulator, attenuates gliosis, decreases levels of proinflammatory mediators, and enhances neuronal viability in glaucoma through activation of the cAMP/PKA pathway. This study provides insight into PDE4 signaling as a potential target to counter the harmful effects associated with chronic gliosis and neuroinflammation in glaucoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
Tham, Y.-C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C.-Y. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.013 · Cited by 7,159
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089
Axonal transport deficits and neurodegenerative diseases
Millecamps, S., & Julien, J.-P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3380 · Cited by 755
Nadal-Nicola´s, F. M., Jime´nez-Lo´pez, M., Sobrado-Calvo, P., Nieto-Lo´pez, L., Ca´novas-Marti´nez, I., Salinas-Navarro, M., Vidal-Sanz, M., & Agudo, M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3267 · Cited by 541
Depolarization and cAMP Elevation Rapidly Recruit TrkB to the Plasma Membrane of CNS Neurons
Meyer-Franke, A., Wilkinson, G. A., Kruttgen, A., Hu, M., Munro, E., Hanson, M. G., Reichardt, L. F., & Barres, B. A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80586-3 · Cited by 516
Howell, G. R., Macalinao, D. G., Sousa, G. L., Walden, M., Soto, I., Kneeland, S. C., Barbay, J. M., King, B. L., Marchant, J. K., Hibbs, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44646 · Cited by 473
Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1
Imai, Y., & Kohsaka, S. (2002) · Glia · doi:10.1002/glia.10149 · Cited by 359 · cited 1×
“To determine whether ibudilast exerted an effect on microgliosis, we first carried out retinal and optic nerve immunolabeling with Iba1, a pan-microglia and macrophage marker (Imai and Kohsaka, 2002).”
Distal axonopathy with structural persistence in glaucomatous neurodegeneration
Crish, S. D., Sappington, R. M., Inman, D. M., Horner, P. J., & Calkins, D. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913141107 · Cited by 350
Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256
Cueva Vargas, J. L., Osswald, I. K., Unsain, N., Aurousseau, M. R., Barker, P. A., Bowie, D., & Di Polo, A. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1273-15.2015 · Cited by 132 · cited 9×
“This procedure leads to blockade of aqueous humor outflow, gradual increase of eye pressure and selective loss of RGC soma and axons (Almasieh et al., 2010; Cueva Vargas et al., 2015; Zhou et al., 2005).”
Influential
Research works printed but not linked: 101
- Abbott, 2014, Comparison of retinal nerve fiber layer thickness in vivo and axonal transport after chronic intraocular pressure elevation in young versus older rats, PLoS ONE, 9, 10.1371/journal.pone.0114546 · DOI
- Ahlers, 2015, Transient activation of microglia following acute alcohol exposure in developing mouse neocortex is primarily driven by BAX-dependent neurodegeneration, Glia, 63, 1694, 10.1002/glia.22835 · DOI · Paper page
- Ahmed, 2004, Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure, Invest. Ophthalmol. Vis. Sci., 45, 1247, 10.1167/iovs.03-1123 · DOI · Paper page
- Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat. Neurosci., 10, 1538, 10.1038/nn2014 · DOI · Paper page
- Almasieh, 2010, Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors, Cell Death Dis., 1, 10.1038/cddis.2009.23 · DOI · Paper page
- Almasieh, 2013, Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma, Invest. Ophthalmol. Vis. Sci., 54, 3171, 10.1167/iovs.12-11481 · DOI
- Angelucci, 1996, Anterograde axonal tracing with the subunit B of cholera toxin: a highly sensitive immunohistochemical protocol for revealing fine axonal morphology in adult and neonatal brains, J. Neurosci. Methods, 65, 101, 10.1016/0165-0270(95)00155-7 · DOI · Paper page
- Atkins, 2007, Modulation of the cAMP signaling pathway after traumatic brain injury, Exp. Neurol., 208, 145, 10.1016/j.expneurol.2007.08.011 · DOI
- Ba, 2015, Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis, Drug Des. Devel. Ther., 9, 5397
- Bacher, 2010, The role of macrophage migration inhibitory factor in Alzheimer's disease, Mol. Med., 16, 116, 10.2119/molmed.2009.00123 · DOI · Paper page
- Bausher, 1995, Regulation of cyclic AMP production in adult human ciliary processes, Exp. Eye Res., 60, 43, 10.1016/S0014-4835(05)80082-X · DOI
- Bode, 1993, Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium, J. Pharmacol. Exp. Ther., 267, 1286, 10.1016/S0022-3565(25)39578-9 · doi:10.1016/s0022-3565(25)39578-9
- Bosco, 2011, Early microglia activation in a mouse model of chronic glaucoma, J. Comp. Neurol., 519, 599, 10.1002/cne.22516 · DOI · Paper page
- Bosco, 2012, Early reduction of microglia activation by irradiation in a model of chronic glaucoma, PLoS ONE, 7, 10.1371/journal.pone.0043602 · DOI · Paper page
- Cen, 2015, Bilateral retinal microglial response to unilateral optic nerve transection in rats, Neuroscience, 311, 56, 10.1016/j.neuroscience.2015.09.067 · DOI
- Charbonneau, 1986, Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species, Proc. Natl. Acad. Sci. U. S. A., 83, 9308, 10.1073/pnas.83.24.9308 · doi:10.1073/pnas.83.24.9308
- Chidlow, 2012, Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells, Neurobiol. Dis., 48, 568, 10.1016/j.nbd.2012.07.026 · DOI · Paper page
- Chong, 2015, Glial cell interactions and glaucoma, Curr. Opin. Ophthalmol., 26, 73, 10.1097/ICU.0000000000000125 · DOI · Paper page
- Corredor, 2012, Soluble adenylyl cyclase activity is necessary for retinal ganglion cell survival and axon growth, J. Neurosci., 32, 7734, 10.1523/JNEUROSCI.5288-11.2012 · DOI
- Cui, 2003, Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons, Mol. Cell. Neurosci., 22, 49, 10.1016/S1044-7431(02)00037-4 · DOI · Paper page
- Dal Piaz, 2000, Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies, Eur. J. Med. Chem., 35, 463, 10.1016/S0223-5234(00)00179-3 · DOI
- Dengler-Crish, 2014, Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma, Front. Neurosci., 8, 290, 10.3389/fnins.2014.00290 · DOI · Paper page
- Dostmann, 1995, (RP)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition, FEBS Lett., 375, 231, 10.1016/0014-5793(95)01201-O · DOI
- Ebneter, 2010, Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury, Invest. Ophthalmol. Vis. Sci., 51, 6448, 10.1167/iovs.10-5284 · DOI · Paper page
- Firth, 2005, Retinal waves: mechanisms and function in visual system development, Cell Calcium, 37, 425, 10.1016/j.ceca.2005.01.010 · DOI
- Fujino, 2009, Axonal protection by brain-derived neurotrophic factor associated with CREB phosphorylation in tumor necrosis factor-alpha-induced optic nerve degeneration, Acta Neuropathol., 117, 75, 10.1007/s00401-008-0440-9 · DOI
- Galindo-Romero, 2013, Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia, Invest. Ophthalmol. Vis. Sci., 54, 974, 10.1167/iovs.12-11207 · DOI
- Gerlo, 2011, Cyclic AMP: a selective modulator of NF-kappaB action, Cell. Mol. Life Sci., 68, 3823, 10.1007/s00018-011-0757-8 · DOI · Paper page
- Gibson, 2006, The inhibitory profile of ibudilast against the human phosphodiesterase enzyme family, Eur. J. Pharmacol., 538, 39, 10.1016/j.ejphar.2006.02.053 · DOI
- Goldberg, 2002, Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity, Neuron, 33, 689, 10.1016/S0896-6273(02)00602-5 · DOI · Paper page
- Gramlich, 2013, Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina, PLoS ONE, 8, 10.1371/journal.pone.0057557 · DOI · Paper page
- Hernandez, 2008, Astrocytes in glaucomatous optic neuropathy, Prog. Brain Res., 173, 353, 10.1016/S0079-6123(08)01125-4 · DOI · Paper page
- Houslay, 2010, Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown, Trends Biochem. Sci., 35, 91, 10.1016/j.tibs.2009.09.007 · DOI · Paper page
- Houslay, 2005, Keynote review: phosphodiesterase-4 as a therapeutic target, Drug Discov. Today, 10, 1503, 10.1016/S1359-6446(05)03622-6 · DOI · Paper page
- Howell, 2012, Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma, J. Clin. Invest., 122, 1246, 10.1172/JCI61135 · DOI · Paper page
- Huang, 2006, Preferential inhibition of human phosphodiesterase 4 by ibudilast, Life Sci., 78, 2663, 10.1016/j.lfs.2005.10.026 · DOI
- Inacio, 2011, Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke, J. Cereb. Blood Flow Metab., 31, 1093, 10.1038/jcbfm.2010.194 · DOI · Paper page
- Inman, 2007, Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma, Glia, 55, 942, 10.1002/glia.20516 · DOI · Paper page
- Inoue, 2008, Effect of ibudilast on non-specific symptoms in patients with chronic cerebral ischemia, Arzneimittelforschung, 58, 277
- Iona, 1998, Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain, Mol. Pharmacol., 53, 23, 10.1124/mol.53.1.23 · DOI
- Johnson, 2009, Friend or foe?Resolving the impact of glial responses in glaucoma, J. Glaucoma, 18, 341, 10.1097/IJG.0b013e31818c6ef6 · DOI · Paper page
- Kuehn, 2008, Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion, Exp. Eye Res., 87, 89, 10.1016/j.exer.2008.04.012 · DOI
- Lebrun-Julien, 2009, Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism, J. Neurosci., 29, 5536, 10.1523/JNEUROSCI.0831-09.2009 · DOI · Paper page
- Lebrun-Julien, 2009, Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion cells, Mol. Cell. Neurosci., 40, 410, 10.1016/j.mcn.2008.12.005 · DOI
- Lebrun-Julien, 2010, ProNGF induces TNFα-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway, Proc. Natl. Acad. Sci. U. S. A., 107, 3817, 10.1073/pnas.0909276107 · DOI · Paper page
- Lee, 2014, Control of outflow resistance by soluble adenylyl cyclase, J. Ocul. Pharmacol. Ther., 30, 138, 10.1089/jop.2013.0199 · DOI
- Leibinger, 2013, Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation, Cell Death Dis., 4, 10.1038/cddis.2013.126 · DOI
- Li, 2003, Axon regeneration in goldfish and rat retinal ganglion cells: differential responsiveness to carbohydrates and cAMP, J. Neurosci., 23, 7830, 10.1523/JNEUROSCI.23-21-07830.2003 · doi:10.1523/jneurosci.23-21-07830.2003
- Mali, 2011, A decrease in phosphorylation of cAMP-response element-binding protein (CREBP) promotes retinal degeneration, Exp. Eye Res., 92, 528, 10.1016/j.exer.2011.03.017 · DOI
- Matsuda, 1997, Expression of macrophage migration inhibitory factor in rat retina and its immunohistochemical localization, J. Neuroimmunol., 77, 85, 10.1016/S0165-5728(97)00061-1 · DOI
- Mehats, 2002, Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling, Trends Endocrinol. Metab., 13, 29, 10.1016/S1043-2760(01)00523-9 · DOI · Paper page
- Mizuno, 2004, Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia, Neuropharmacol., 46, 404, 10.1016/j.neuropharm.2003.09.009 · DOI · Paper page
- Morrison, 1997, A rat model of chronic pressure-induced optic nerve damage, Exp. Eye Res., 64, 85, 10.1006/exer.1996.0184 · DOI · Paper page
- Morrison, 2015, Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure, Exp. Eye Res., 141, 23, 10.1016/j.exer.2015.05.012 · DOI
- Nakazawa, 2006, Tumor necrosis factor-{alpha} mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma, J. Neurosci., 26, 12633, 10.1523/JNEUROSCI.2801-06.2006 · DOI · Paper page
- Nathanson, 1980, Adrenergic regulation of intraocular pressure: identification of beta 2-adrenergic-stimulated adenylate cyclase in ciliary process epithelium, Proc. Natl. Acad. Sci. U. S. A., 77, 7420, 10.1073/pnas.77.12.7420 · doi:10.1073/pnas.77.12.7420
- Noguchi, 2009, Vasodilator effects of ibudilast on retinal blood vessels in anesthetized rats, Biol. Pharm. Bull., 32, 1924, 10.1248/bpb.32.1924 · doi:10.1248/bpb.32.1924
- Park, 2015, AMPA receptor desensitization is the determinant of AMPA receptor mediated excitotoxicity in purified retinal ganglion cells, Exp. Eye Res., 132, 136, 10.1016/j.exer.2015.01.026 · DOI
- Paterniti, 2014, Phosphodiesterase as a new therapeutic target for the treatment of spinal cord injury and neurodegenerative diseases, Curr. Med. Chem., 21, 2830, 10.2174/0929867321666140217102428 · doi:10.2174/0929867321666140217102428
- Pearce, 2015, Advances in drug delivery to the posterior segment, Curr. Opin. Ophthalmol., 26, 233, 10.1097/ICU.0000000000000143 · DOI
- Pearse, 2004, cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury, Nat. Med., 10, 610, 10.1038/nm1056 · DOI · Paper page
- Penfold, 1991, Antibodies to human leucocyte antigens indicate subpopulations of microglia in human retina, Vis. Neurosci., 7, 383, 10.1017/S0952523800004879 · DOI · Paper page
- Popp, 2009, Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease, J. Psychiatr. Res., 43, 749, 10.1016/j.jpsychires.2008.10.006 · DOI
- Poulsen, 2014, Primary culture of trigeminal satellite glial cells: a cell-based platform to study morphology and function of peripheral glia, Int. J. Physiol. Pathophysiol. Pharmacol., 6, 1
- Prinz, 2011, Microglia in the CNS: immigrants from another world, Glia, 59, 177, 10.1002/glia.21104 · DOI · Paper page
- Reichenbach, 2013, New functions of Müller cells, Glia, 61, 651, 10.1002/glia.22477 · DOI · Paper page
- Ren, 2010, A role for complement in glaucoma?, Adv. Exp. Med. Biol., 703, 95, 10.1007/978-1-4419-5635-4_7 · DOI
- Rodgers, 2014, Reversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppression, J. Neurotrauma, 31, 487, 10.1089/neu.2013.3090 · DOI
- Rojas, 2014, Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers, J. Neuroinflammation, 11, 133, 10.1186/1742-2094-11-133 · DOI · Paper page
- Rolan, 2009, Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease, Expert. Opin. Pharmacother., 10, 2897, 10.1517/14656560903426189 · DOI · Paper page
- Ruzafa, 2015, Effect of Müller cells on the survival and neuritogenesis in retinal ganglion cells, Arch Soc Esp Oftalmol., 90, 522, 10.1016/j.oftal.2015.03.009 · doi:10.1016/j.oftal.2015.03.009
- Sachs, 2007, Regulation of cAMP by the p75 neurotrophin receptor: insight into drug design of selective phosphodiesterase inhibitors, Biochem. Soc. Trans., 35, 1273, 10.1042/BST0351273 · DOI
- Sanchez, 2003, Interleukin-6 in retinal ischemia reperfusion injury in rats, Invest. Ophthalmol. Vis. Sci., 44, 4006, 10.1167/iovs.03-0040 · DOI · Paper page
- Schaal, 2012, The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury, PLoS ONE, 7, 10.1371/journal.pone.0043634 · DOI
- Schwartz, 2008, Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation, Prog. Brain Res., 173, 375, 10.1016/S0079-6123(08)01126-6 · DOI
- Schwartz, 2009, Immune maintenance in glaucoma: boosting the body's own neuroprotective potential, J. Ocul. Biol. Dis. Infor., 2, 73, 10.1007/s12177-009-9025-7 · DOI
- Scott, 1991, Cyclic nucleotide-dependent protein kinases, Pharmacol. Ther., 50, 123, 10.1016/0163-7258(91)90075-W · DOI · Paper page
- Stasi, 2006, Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes, Invest. Ophthalmol. Vis. Sci., 47, 1024, 10.1167/iovs.05-0830 · DOI · Paper page
- Stellwagen, 1999, Dynamics of retinal waves are controlled by cyclic AMP, Neuron, 24, 673, 10.1016/S0896-6273(00)81121-6 · DOI · Paper page
- Stevens, 2007, The classical complement cascade mediates CNS synapse elimination, Cell, 131, 1164, 10.1016/j.cell.2007.10.036 · DOI · Paper page
- Stewart, 2015, The clinical utility of aflibercept for diabetic macular edema, Diabetes Metab. Syndr. Obes., 8, 473, 10.2147/DMSO.S72792 · DOI
- Sun, 2013, Reversible reactivity by optic nerve astrocytes, Glia, 61, 1218, 10.1002/glia.22507 · DOI · Paper page
- Suzumura, 1999, Ibudilast suppresses TNF-alpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS, Brain Res., 837, 203, 10.1016/S0006-8993(99)01666-2 · DOI
- Tezel, 2013, Immune regulation toward immunomodulation for neuroprotection in glaucoma, Curr. Opin. Pharmacol., 13, 23, 10.1016/j.coph.2012.09.013 · DOI
- Tezel, 2004, Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice, Brain Res., 996, 202, 10.1016/j.brainres.2003.10.029 · DOI · Paper page
- Tezel, 2010, Oxidative stress and the regulation of complement activation in human glaucoma, Invest. Ophthalmol. Vis. Sci., 51, 5071, 10.1167/iovs.10-5289 · DOI · Paper page
- Tezel, 2012, An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma, Invest. Ophthalmol. Vis. Sci., 53, 4220, 10.1167/iovs.11-9101 · DOI · Paper page
- Travaglione, 2002, Epithelial cells and expression of the phagocytic marker CD68: scavenging of apoptotic bodies following rho activation, Toxicol. in Vitro, 16, 405, 10.1016/S0887-2333(02)00028-0 · DOI
- Vecino, 2016, Glia–neuron interactions in the mammalian retina, Prog Ret Eye Res., 51, 1, 10.1016/j.preteyeres.2015.06.003 · DOI · Paper page
- Wang, 2002, Immunohistologic evidence for retinal glial cell changes in human glaucoma, Invest. Ophthalmol. Vis. Sci., 43, 1088
- Wang, 2014, Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina, J. Neurosci., 34, 3793, 10.1523/JNEUROSCI.3153-13.2014 · DOI · Paper page
- Watanabe, 2003, Intravitreal injections of neurotrophic factors and forskolin enhance survival and axonal regeneration of axotomized beta ganglion cells in cat retina, Neuroscience, 116, 733, 10.1016/S0306-4522(02)00562-6 · DOI
- Weinreb, 2004, Primary open-angle glaucoma, Lancet, 363, 1711, 10.1016/S0140-6736(04)16257-0 · DOI · Paper page
- Whitaker, 2009, The novel distribution of phosphodiesterase-4 subtypes within the rat retina, Neuroscience, 163, 1277, 10.1016/j.neuroscience.2009.07.045 · DOI
- Wilson, 2015, Early pro-inflammatory cytokine elevations in the DBA/2J mouse model of glaucoma, J. Neuroinflammation, 12, 176, 10.1186/s12974-015-0399-0 · DOI
- Wohl, 2010, Proliferative response of microglia and macrophages in the adult mouse eye after optic nerve lesion, Invest. Ophthalmol. Vis. Sci., 51, 2686, 10.1167/iovs.09-4537 · DOI
- Yang, 2011, Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina, Invest. Ophthalmol. Vis. Sci., 52, 8442, 10.1167/iovs.11-8152 · DOI · Paper page
- Yoshioka, 1998, Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity, J. Neurochem., 70, 2416, 10.1046/j.1471-4159.1998.70062416.x · DOI
- Yuan, 2001, Activated microglia in the human glaucomatous optic nerve head, J. Neurosci. Res., 64, 523, 10.1002/jnr.1104 · DOI · Paper page
- Zhou, 2005, Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma, Mol. Ther., 12, 402, 10.1016/j.ymthe.2005.04.004 · DOI · Paper page
- Zhu, 2001, The antidepressant and antiinflammatory effects of rolipram in the central nervous system, CNS Drug Rev., 7, 387, 10.1111/j.1527-3458.2001.tb00206.x · DOI · Paper page
Cited by
Inflammation in Glaucoma: From the back to the front of the eye, and beyond
Baudouin, C., Kolko, M., Melik-Parsadaniantz, S., & Messmer, E. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100916 · Cited by 454
Margeta, M. A., Yin, Z., Madore, C., Pitts, K. M., Letcher, S. M., Tang, J., Jiang, S., Gauthier, C. D., Silveira, S. R., Schroeder, C. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.014 · Cited by 130
Neuroprotection in Glaucoma: Animal Models and Clinical Trials
Almasieh, M., & Levin, L. A. (2017) · Annual Review of Vision Science · doi:10.1146/annurev-vision-102016-061422 · Cited by 111
“…can facilitate RGC death, given the findings that intraocular application of drugs such as ibudilast (a cAMP phosphodiesterase inhibitor) (Cueva Vargas et al. 2016) or candesartan (an angiotensin II type 1 receptor antagonist) (Semba et al. 2014) significantly improved RGC survival in glaucoma…”
BackgroundBelforte, N., Agostinone, J., Alarcon-Martinez, L., Villafranca-Baughman, D., Dotigny, F., Cueva Vargas, J. L., & Di Polo, A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00466-z · Cited by 67
“Optic nerve cross sections were prepared as described [27] and incubated with primary antibodies against the panmicroglia and macrophage marker Iba1 (ionized calciumbinding adapter molecule 1, 1.”
MethodSelf-citation
Metadata
- Authors
- Cueva Vargas, J. L., Belforte, N., & Di Polo, A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 93
- Pages
- 156-171
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2369799003
- Cited by
- 60
- References
- 10
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Canadian Institutes of Health Research (CIHR-VIH-105439)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.